MUSSALLEM MICHAEL A 4
4 · Edwards Lifesciences Corp · Filed Feb 5, 2024
Insider Transaction Report
Form 4
MUSSALLEM MICHAEL A
DirectorChairman & CEO
Transactions
- Exercise/Conversion
Common Stock
2024-02-05$36.75/sh+29,350$1,078,613→ 33,835.82 total - Sale
Common Stock
2024-02-05$88.63/sh−6,422$569,182→ 26,413.82 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2024-02-05−29,350→ 88,050 totalExercise: $36.75From: 2017-06-11Exp: 2024-05-10→ Common Stock (29,350 underlying) - Sale
Common Stock
2024-02-05$86.44/sh−9,761$843,741→ 16,652.82 total - Sale
Common Stock
2024-02-05$89.61/sh−1,000$89,610→ 32,835.82 total - Sale
Common Stock
2024-02-05$87.55/sh−12,167$1,065,221→ 4,485.82 total
Holdings
- 4,038,377(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $89.390 to $90.080. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $88.210 to $89.200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $86.100 to $87.070. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $87.110 to $88.105. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.